Beijing Sun-Novo Pharmaceutical Research Co Ltd - ESG Rating & Company Profile powered by AI
This assessment of Beijing Sun-Novo Pharmaceutical Research Co Ltd leverages information from across the web as well as from available filings by Beijing Sun-Novo Pharmaceutical Research Co Ltd. Full Sustainability analysis of Beijing Sun-Novo Pharmaceutical Research Co Ltd can be reached by signing in. If you work at Beijing Sun-Novo Pharmaceutical Research Co Ltd and you would like to use your Sustainability aseessment, please contact us.
Beijing Sun-Novo Pharmaceutical Research Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Beijing Sun-Novo Pharmaceutical Research Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose current and historical energy intensity?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd report the average age of the workforce?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd reference operational or capital allocation in relation to climate change?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose its ethnicity pay gap?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose cybersecurity risks?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd offer flexible work?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose the number of employees in R&D functions?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd conduct supply chain audits?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd conduct 360 degree staff reviews?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose the individual responsible for D&I?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose current and / or historical scope 2 emissions?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose water use targets?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd have careers partnerships with academic institutions?
Did Beijing Sun-Novo Pharmaceutical Research Co Ltd have a product recall in the last two years?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose incidents of discrimination?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Beijing Sun-Novo Pharmaceutical Research Co Ltd issued a profit warning in the past 24 months?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose parental leave metrics?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose climate scenario or pathway analysis?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose the pay ratio of women to men?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd support suppliers with sustainability related research and development?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Beijing Sun-Novo Pharmaceutical Research Co Ltd involved in embryonic stem cell research?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose GHG and Air Emissions intensity?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose its waste policy?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd report according to TCFD requirements?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose energy use targets?
Does Beijing Sun-Novo Pharmaceutical Research Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Beijing Sun-Novo Pharmaceutical Research Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Beijing Sun-Novo Pharmaceutical Research Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research services; consistency evaluation services; clinical research services; registration consulting and agency services; and range of pharmacokinetics-pharmacodynamics and GLP bioanalysis services, including pharmacokinetic bioanalysis, immunogenic biology analysis, pharmacodynamics, and biomarker bioanalysis services. The company was founded in 2009 and is based in Beijing, China.